Health News
Personalizing Blood Cancer Treatment
Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is to provide what’s best for the individual patient.
No Need to Fear Lupus Medications
Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?
Battling Fatigue Decades Later
Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.
Closing in On Why Kids Get Cancer
With some forms of cancer, race matters. New research may explain why Hispanic children are more prone to a type of blood cancer.
Closing In on a Cure
Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances are vastly greater.
Experimental Treatment May Extend Leukemia Survival
One of the challenges of leukemia is that it likes to return. Once the blood cancer comes back, it’s more difficult to treat and beat. Medical scientists are experimenting with a way to boost the body’s immune system to get in on the fight and win.
Keeping Track of CML
Staying on top of a chronic disease is key to staying well. Managing these diseases can be tricky. Chronic myeloid leukemia (CML) is a great example.
Cancer Risks of Cancer Treatment
You do what you can – what you’re told – to beat the cancer. Chemotherapy is recommended and it works. Years later, though, you’re diagnosed with a blood cancer that could be related to the chemotherapy. Is this really happening?
Cancer Rx Granted Accelerated FDA Approval Path
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.
Living With Chronic Myeloid Leukemia
People diagnosed with chronic myeloid leukemia (CML) are living longer than ever before. A number of effective therapies are available for all phases of the disease, but living with CML has its challenges.